ctrl K

Price Alert

Vera Therapeutics Inc. (VERA)

NASDAQ: VERA · Real-Time Price · USD

21.55

0.28 (1.32%)

At close: Aug 15, 2025, 3:59 PM

21.21

-1.58%

After-hours: Aug 15, 2025, 07:17 PM EDT

Vera Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	92.65M	45.68M	114.65M	79.67M
Short-Term Investments	548.21M	115.03M	71.19M	n/a
Long-Term Investments	n/a	11K	58K	867K
Other Long-Term Assets	131K	471K	506K	344K
Receivables	3.77M	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	913K	3.22M	719K	480K
Total Current Assets	651.22M	172.02M	125.7M	82.54M
Property-Plant & Equipment	4.33M	3.04M	5.17M	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	4.46M	3.52M	5.74M	1.21M
Total Assets	655.68M	175.55M	131.44M	83.75M
Account Payables	7.67M	11.12M	11.99M	1.39M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	1.48M	n/a	2.65M	n/a
Other Current Liabilities	9.18M	4.82M	5.1M	4.85M
Total Current Liabilities	25.37M	22.3M	25.6M	7.69M
Long-Term Debt	50.69M	49.88M	24.81M	4.92M
Other Long-Term Liabilities	n/a	286K	286K	1.54M
Total Long-Term Liabilities	53.16M	51.56M	28.93M	6.47M
Total Liabilities	78.53M	73.86M	54.53M	14.16M
Total Debt	54.64M	53.71M	31.29M	4.92M
Common Stock	64K	44K	28K	21K
Retained Earnings	-461.25M	-309.1M	-213.11M	-124.06M
Comprehensive Income	393K	251K	-224K	-83.75M
Shareholders Equity	577.15M	101.69M	76.91M	69.59M
Total Investments	548.21M	115.05M	71.25M	867K